MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jinf.2018.08.003

Медицинская библиотека · The Journal of infection · 2018

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.

Borisov Sergey E, D'Ambrosio Lia, Centis Rosella, Tiberi Simon, Dheda Keertan, Alffenaar Jan-Willem, Amale Rohit, Belilowski Evgeny, Bruchfeld Judith, Canneto Barbara, Denholm Justin, Duarte Raquel, Esmail Aliasgar, Filippov Alex, Davies Forsman Lina, Gaga Mina, Ganatra Shashank, Igorevna Gaida Anastasia, Lazaro Mastrapa Barbara, Manfrin Vinicio, Manga Selene, Maryandyshev Andrey, Massard Gilbert, González Montaner Pablo, Mullerpattan Jai, Palmero Domingo Juan, Pontarelli Agostina, Papavasileiou Apostolos, Pontali Emanuele, Romero Leyet Rodolfo, Spanevello Antonio, Udwadia Zarir Farokh, Viggiani Pietro, Visca Dina, Sotgiu Giovanni, Migliori Giovanni Battista

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

No study evaluated the contribution of adjunctive surgery in bedaquiline-treated patients. This study describes treatment outcomes and complications in a cohort of drug-resistant pulmonary tuberculosis (TB) cases treated with bedaquiline-containing regimens undergoing surgery.

METHODS

This retrospective observational study recruited patients treated for TB in 12 centres in 9 countries between January 2007 and March 2015. Patients who had surgical indications in a bedaquiline-treated programme-based cohort were selected and surgery-related information was collected. Patient characteristics and surgical indications were described together with type of operation, surgical complications, bacteriological conversion rates, and treatment outcomes. Treatment outcomes were evaluated according to the time of surgery.

RESULTS

57 bedaquiline-exposed cases resistant to a median of 7 drugs had indication for surgery (52 retreatments; 50 extensively drug-resistant (XDR) or pre XDR-TB). Sixty percent of cases initiated bedaquiline treatment following surgery, while 36.4% underwent the bedaquiline regimen before surgery and completed it after the operation. At treatment completion 90% culture-converted with 69.1% achieving treatment success; 21.8% had unfavourable outcomes (20.0% treatment failure, 1.8% lost to follow-up), and 9.1% were still undergoing treatment.

CONCLUSIONS

The study results suggest that bedaquiline and surgery can be safely and effectively combined in selected cases with a specific indication.

Для цитирования: Borisov Sergey E, D'Ambrosio Lia, Centis Rosella, Tiberi Simon, Dheda Keertan, Alffenaar Jan-Willem, Amale Rohit, Belilowski Evgeny, Bruchfeld Judith, Canneto Barbara, Denholm Justin, Duarte Raquel, Esmail Aliasgar, Filippov Alex, Davies Forsman Lina, Gaga Mina, Ganatra Shashank, Igorevna Gaida Anastasia, Lazaro Mastrapa Barbara, Manfrin Vinicio, Manga Selene, Maryandyshev Andrey, Massard Gilbert, González Montaner Pablo, Mullerpattan Jai, Palmero Domingo Juan, Pontarelli Agostina, Papavasileiou Apostolos, Pontali Emanuele, Romero Leyet Rodolfo, Spanevello Antonio, Udwadia Zarir Farokh, Viggiani Pietro, Visca Dina, Sotgiu Giovanni, Migliori Giovanni Battista. Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.. The Journal of infection. 2018. DOI: 10.1016/j.jinf.2018.08.003.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.